More girls and boys getting the HPV vaccine in Denmark

In 2009, the Human Papillomavirus (HPV) vaccine was introduced to the Danish children’s vaccination program for girls aged 12-18. 

Ten years later it was expanded to include 12-year-old boys in a development that has been widely praised as a resounding success.

New figures from the State Serum Institute (SSI) have shown that 85 percent of 12-year-old girls and 82 percent of boys of the same age got the first of two HPV vaccines in 2020.

And of them, 42 percent of the girls and 38 percent of the boys have got the second vaccination and thus completed the treatment.

Read More

University of Copenhagen: Covid-19 vaccine candidate based on UCPH-research ready for testing on humans

A few days from now the first human will be vaccinated with a Danish vaccine candidate against COVID-19. It is developed by a team of researchers at the University of Copenhagen in collaboration with the companies AdaptVac, ExpreS2ion Biotechnologies and Bavarian Nordic. The vaccine candidate, ABNCoV2, has just been approved for human clinical testing. So far, the research data look promising.

’Our vaccine candidate is characterised in that it elicits a strong immune response in animals. We hope and believe that the strong immune response both results in effective and long-lasting protection’, says Professor Ali Salanti.

Read More